Branded and Biosimilar Ophthalmology
Awarded to Bayer Plc, Biogen Idec Ltd, Celltrion Healthcare United Kingdom Limited +4 more
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)(buyer)
- Published
- Published 6 August 2025
- Deadline
- Closed 5 September 2025
Tender documents
Skim pulls every file the buyer attaches to this process and extracts the requirements from it.
Documents as they publish
Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.
Overview
Contracting authority
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
BuyerEdinburgh, United Kingdom
Authority website ↗
Find the key decision makers
The people who scope, score and sign this contract — names, roles and how to reach them.
Lots (4)
Aflibercept (Eylea®)
Supply of Aflibercept (Eylea®) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.
£89,785,600Won by Bayer PlcAflibercept Biosimilar
Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.
£1Won by Mercury Pharmaceuticals LimitedWon by Teva UK LtdWon by Celltrion Healthcare United Kingdom LimitedWon by MD BiologicsWon by SandozRanibizumab vials and Pre-filled Syringes
Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.
£5,056,988Won by Biogen Idec LtdWon by Teva UK LtdFaricimab (Vabysmo®)
Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.
£51,736,628
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £146,579,216
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 6 August 2025
- Deadline
- Closed
Award outcome
- Awarded value
- £20,671,084
- Award date
- 30 October 2025
- Contract period
- — → 25 October 2026
- Bayer Plc
- Biogen Idec Ltd
- Celltrion Healthcare United Kingdom Limited
- MD Biologics
- Mercury Pharmaceuticals Limited
- Sandoz
- Teva UK Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
24 November 2025
Contract Notice
6 August 2025
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
How to win this tender
Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.
See exactly how Skim’s agents do this →
Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.
Find tenders like this before your competitors do.
Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.